Michael Gold to Genital Neoplasms, Female
This is a "connection" page, showing publications Michael Gold has written about Genital Neoplasms, Female.
Connection Strength
0.861
-
A6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial. Gynecol Oncol. 2005 Oct; 99(1):50-7.
Score: 0.239
-
Amifostine pretreatment for protection against topotecan-induced hematologic toxicity: results of a multicenter phase III trial in patients with advanced gynecologic malignancies. Gynecol Oncol. 2003 Aug; 90(2):325-30.
Score: 0.206
-
We need a new paradigm in gynecologic cancer care: SGO proposes solutions for delivery, quality and reimbursement policies. Gynecol Oncol. 2013 Apr; 129(1):3-4.
Score: 0.101
-
Effect of methylphenidate on fatigue in women with recurrent gynecologic cancer. Psychooncology. 2010 Sep; 19(9):955-8.
Score: 0.084
-
Distress in women with gynecologic cancer. Psychooncology. 2010 Jun; 19(6):665-8.
Score: 0.083
-
Outpatient implantation of a central venous access system in gynecologic oncology patients. J Reprod Med. 2003 Nov; 48(11):875-81.
Score: 0.052
-
Impact of individual physicians on enrollment of patients into clinical trials. Am J Clin Oncol. 2003 Apr; 26(2):171-3.
Score: 0.050
-
Panniculectomy with simultaneous gynecologic oncology surgery. Gynecol Oncol. 2001 Dec; 83(3):518-22.
Score: 0.046